A Swiss contract research organization, Solvias, is establishing a cell- and gene-therapy (CGT) testing center in Morrisville ...

The Small Business Research Loan program provides investments of $150,000 to $350,000 into innovative early-stage life sciences companies in North Carolina. The program supports: Business inception ...

Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm ...

Attend the NC Biotech Career Symposium hosted by Humacyte held Wednesday, June 5 at the North Carolina Biotechnology Center. Inspire and recruit students, recent graduates and professionals through ...

With North Carolina’s biopharmaceutical manufacturing industry continuing to expand, two college-based programs are working to stay ahead of the growth by preparing students for promising careers in ...

The researchers engineered the surface of the synthetic platelets to incorporate antibody fragments that bind to a protein ...

There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar ...

Raleigh-based UVision360 has achieved a dual-indication 510(k) clearance from the U.S. Food and Drug Administration for its all-in-one gynecological system LUMINELLE DTx Hysteroscopy System. The dual ...

North Carolina’s roster of contract research organizations (CROs), already the world’s largest, is a little bit bigger today. Almac Group, a global CRO based in Northern Ireland, has opened a new ...

Durham-based Mycovia Pharmaceuticals, formerly Viamet Pharmaceuticals, has begun two Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women. The trials ...